The global market for dermatology drugs is estimated to be US$31.3 billion in 2023 and is projected to grow to US$47.9 billion by 2027. Market growth has primarily been fueled by the increasing prevalence of dermatological conditions and the rise in R&D expenditure in healthcare. In line with this growth, the dermatology CRO market is projected to reach US$12.8 billion by the end of 2032. Below are ten of the top CROs for dermatology clinical trials.
1. Advanced Clinical
Advanced Clinical is a global CRO and a functional service provider (FSP). As a CRO, Advanced Clinical provides customized solutions from feasibility assessment to study completion, prioritizing trial effectiveness and patient centricity. Using its FSP delivery model, Advanced Clinical effectively partners with sponsors to create and provide tailored functional solutions that help address short-term talent attraction, skill gap, and retention and enable a more scalable and diverse workforce. Advanced Clinical has particular strength in dermatologic studies spanning Phase I-IV trials in all major categories, including drug, biologic, and diagnostic and device studies.
Altasciences is a mid-size CRO offering biopharma companies preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. It has research and manufacturing facilities across North America and over 25 years of experience partnering with sponsors to provide its integrated full-service solutions. The Altasciences Dermatology CRO gives dermatologic expertise to preclinical and clinical research and helps to speed up the transition of molecules – both small and large – through the phases of development.
Dermatology experts work with sponsors from preclinical to proof of concept in locally or centrally acting therapies. Altasciences collaborates with consulting dermatologists who perform specialized assessments for trials, and for products requiring irritation and sensitization studies, Altasciences provides access to dedicated clinic areas with different climates. Altasciences has conducted 200 dermatologic clinical studies.
Biorasi is a full-service US-based global CRO established in 2002. It supports studies conducted in North America, Europe, and Asia Pacific. Unabashedly unconventional, Biorasi claims to be a non-traditional CRO focused on disrupting the clinical trial process. The Biorasi Dermatology CRO has managed dermatological studies for over 15 years and has expertise in complex indications, including atopic dermatitis, acne, rosacea, and psoriasis. Biorasi has a track record of successful studies in atopic dermatitis, plaque psoriasis, and rare dermatology diseases.
During the COVID-19 pandemic, Biorasi reported that 93% of their ongoing clinical trials achieved critical milestones, including first patient, first visit milestones for dermatology trials. Biorasi has scientific and clinical expertise supported by a scientific advisory board of industry experts and key opinion leaders (KOLs).
bioskin is a full-service Dermatology CRO based in Germany with 30 years of experience. bioskin offers global dermatologic consulting and regulatory services, as well as all CRO services for Phase I – IV trials and medical device studies. The bioskin Dermatology CRO describes its strengths as being able to develop innovative test designs, interpret study results, and integrate biophysical measurement methods to deliver objective data about skin function and structure.
5. Innovaderm Research
Innovaderm began as a clinical research site specializing in dermatology in Canada more than twenty years ago. In 2007, Innovaderm initiated Dermatology CRO services as a full service combined with in-house advanced scientific capabilities and an expert clinical site network. It has been involved in studies on psoriasis, acne, and atopic dermatitis and studies involving biologics and photodynamic therapy. In numbers, Innovaderm has been involved in over 500 clinical trials covering more than 30 indications and involving more than 85,000 subjects across over 2,900 sites worldwide.
Founded in 1998, Integrium is a full-service CRO with offices in North America and formal alliances with partners in Europe, Australia, and India. Integrium has the experts, expertise, and experience to manage Phase 1 – 4 cardiovascular, metabolic disease, and dermatology trials for specialty, small, mid-size, and large companies worldwide. Over 100 dermatology clinical trials have been completed, the largest being a diabetic foot ulcer trial involving 1,000 patients in 91 sites across North America.
Founded in 2020, Vial is a next-generation tech-enabled CRO on a mission to reimagine clinical trials to deliver faster and more efficient trials. Clinical Operations leaders with a combined 150 years of experience at CROs and best-in-class product minds from Silicon Valley have joined forces to build the Vial end-to-end technology platform to increase trial efficiency. The Vial Dermatology CRO was created with the understanding and interests of sponsors firmly prioritized. The Dermatology CRO team has extensive experience leading CROs across dermatologic indications. In addition, it works closely with the site operations team to continuously review execution strategies, monitor patient recruitment efforts, and mitigate key study risks for Dermatology clinical trials.
Founded in 2012 in Spain, Sofpromed is a full-service CRO providing global management of Phase I – IV clinical trials across all therapeutic areas. Sofpromed manages trials in the US, Europe, UK, Asia Pacific, Middle East, North Africa, and Latin America. If required, Sofpromed also provides clinical trial staffing to biopharma companies through its FSP. As a Dermatology CRO, Sofpromed manages clinical trials in rosacea, lupus, psoriasis, eczema, vitiligo, dermatitis, scleroderma, herpes zoster, urticaria, amongst others.
Proinnovera is a digital CRO for dermatology and inflammatory diseases providing full CRO services for Phase I – IV clinical trials and non-interventional and medical device studies. Based in Germany, Proinnovera has conducted more than 650 clinical studies in over 40 countries. A leading Dermatology CRO, Proinnovera has over 25 years of dermatological experience and conducted more than 450 dermatologic studies. Other clinical studies include inflammatory disease, oncology, aesthetics, and allergology.
10. Worldwide Clinical Trials
Worldwide Clinical Trials (Worldwide) was founded by physicians driven by their mission to advance medical science and their commitment to operational excellence. Worldwide has clinical operations and medical and scientific personnel working with sponsors in more than 60 countries. The Worldwide Dermatology CRO provides sponsors with advice and support on medical, operational, regulatory, and cost-efficiency issues related to their dermatology clinical trials. Worldwide has experience in burn/wound, dermatitis, eczema, infectious diseases of the skin, psoriasis, rosacea, and wound healing studies.
To learn more about how the Vial CRO’s tech-powered services are delivering faster, more efficient dermatology trial outcomes for dramatically lower costs, connect with a team member today!